Service Quote Request
Please fill out the form below with your detailed inquiry.
Adenovirus (Ad) vectors are among the most versatile and robust gene delivery systems used in molecular biology, gene therapy research, vaccine development, and oncolytic applications. Their high transduction efficiency, broad tropism, and capacity for large genetic payloads make adenovirus an ideal platform for both in vitro and in vivo studies.
Adenoviruses are non-enveloped, double-stranded DNA viruses with a genome of approximately 36 kb. Recombinant adenoviral vectors are typically rendered replication-deficient through deletion of essential early genes (e.g., E1/E3), enabling safe and controlled transgene expression in target cells without viral replication.
Key characteristics include:
Adenovirus achieves rapid and efficient gene delivery across a wide range of cell types, including primary cells that are often difficult to transfect.
With deletions in E1/E3 regions, adenoviral vectors can accommodate up to ~7.5 kb of foreign DNA, supporting complex constructs, large cDNAs, or multi-gene cassettes.
Transgene expression is typically detectable within 24โ48 hours post-transduction, making adenovirus ideal for time-sensitive experiments.
Adenoviral DNA remains episomal, reducing the risk of insertional mutagenesis and making it suitable for applications requiring transient expression.
High-quality adenovirus production requires optimized amplification, purification, and rigorous quality control. Key parameters include:
Reliable manufacturing ensures reproducible performance in downstream experiments.
From construct design to high-titer virus production, adenovirus remains a trusted and powerful tool for gene delivery. Whether you are performing rapid in vitro screening or advancing an in vivo study, adenoviral vectors offer speed, flexibility, and proven performance.
Ready to get started? Explore adenovirus-based solutions designed to accelerate your research and deliver dependable results, please contact us at info@signagen.com